Product Name: LDB1 antibody [N2C3]
Applications: ICC/IF, IHC-P, IP, WB
Predicted Target Size: 47 kDa (note) (3)
Positive Controls: 293T , A431 , HeLa , HepG2 , Mouse brain
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: LIM domain binding 1
Background: Binds to the LIM domain of a wide variety of LIM domain-containing transcription factors. May regulate the transcriptional activity of LIM-containing proteins by determining specific partner interactions. May play a role in the development of motor neurons. Acts synergistically with LHX1/LIM1 in axis formation and activation of gene expression. Acts with LMO2 in the regulation of red blood cell development, maintaining erythroid precursors in an immature state.
Synonyms: CLIM2 antibody, NLI antibody, LDB1 antibody, CLIM-2 antibody, hLdb1 antibody, LDB-1 antibody, LIM domain-binding factor-1 antibody, nuclear LIM interactor antibody, LIM domain-binding factor CLIM2 antibody, carboxyl-terminal LIM domain-binding protein 2 antibody, carboxy terminal LIM domain protein 2 antibody, LIM domain-binding protein 1 antibody, LIM domain binding 1 antibody
Cellular Localization: Nucleus
CAS NO: 122795-43-1
Product: Amikacin (sulfate)
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the center region of human LDB1. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human, Mouse, Rat
Conjugation: Unconjugated
Storage Buffer: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/23471973?dopt=Abstract
